Literature DB >> 20790097

Studies of the Inferior Vena Cava in Late Pregnancy.

M G Kerr, D B Scott, E Samuel.   

Abstract

Entities:  

Year:  1964        PMID： 20790097

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

Review 1.  Pregnancy and vascular liver disease.

Authors:  Julien Bissonnette; François Durand; Emmanuelle de Raucourt; Pierre-François Ceccaldi; Aurélie Plessier; Dominique Valla; Pierre-Emmanuel Rautou
Journal:  J Clin Exp Hepatol       Date:  2015-01-06

2.  Left tilt position for easy extracorporeal membrane oxygenation cannula insertion in late pregnancy patients.

Authors:  William Ngatchou; Ahmed S E Ramadan; Guido Van Nooten; Martine Antoine
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-04-23

3.  An Individual Participant Data Meta-analysis of Maternal Going-to-Sleep Position, Interactions with Fetal Vulnerability, and the Risk of Late Stillbirth.

Authors:  Robin S Cronin; Minglan Li; John M D Thompson; Adrienne Gordon; Camille H Raynes-Greenow; Alexander E P Heazell; Tomasina Stacey; Vicki M Culling; Victoria Bowring; Ngaire H Anderson; Louise M O'Brien; Edwin A Mitchell; Lisa M Askie; Lesley M E McCowan
Journal:  EClinicalMedicine       Date:  2019-04-02

4.  Unusual presentation of supraventricular tachycardia degenerating into ventricular fibrillation during pregnancy: Aortocaval compression the probable culprit.

Authors:  Abhisheik Prashar; Sarah Ming Li Tan; Andrew Hopkins; Rahn Ilsar
Journal:  Indian Pacing Electrophysiol J       Date:  2022-01-11

5.  Associations between symptoms of sleep-disordered breathing and maternal sleep patterns with late stillbirth: Findings from an individual participant data meta-analysis.

Authors:  Robin S Cronin; Jessica Wilson; Adrienne Gordon; Minglan Li; Vicki M Culling; Camille H Raynes-Greenow; Alexander E P Heazell; Tomasina Stacey; Lisa M Askie; Edwin A Mitchell; John M D Thompson; Lesley M E McCowan; Louise M O'Brien
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.